|
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults Clinical research trials and HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults. HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults clinical trial. Human subjects often get the best healthcare possible for their HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults  HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
For Condition: HIV Seronegativity,HIV Infections
Status: No longer recruiting
Sponsor(s): Walter Reed Army Institute of Research (WRAIR) ,
Synopsis: The purpose of this study is to determine the best way to administer the candidate HIV vaccine, ALVAC HIV-1 (vCP205).
Details: Healthy adult volunteers are assigned randomly to either a vaccine or placebo group. Injections are received either intramuscularly, intradermally, or by delivery under the skin of the volunteer's own white blood cells which have had dendritic cell reinfusion. Volunteers are vaccinated at 0, 1, 3, and 6 month time points. Volunteers are closely monitored for 1 hour after vaccination and keep a diary of symptoms for 1 week post-immunization. Volunteers undergo leukopheresis at the start of the study and after the last vaccination at Walter Reed Army Medical Center. Volunteers receive compensation benefits.
Eligibility:
Study Type: Interventional, Prevention
Minimum Age/Maximum Age: 18 Years/55 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Volunteers may be eligible for this study if they: - Are legal US residents. - Are healthy adults from 18 to 55 years of age. Exclusion Criteria Volunteers will not be eligible for this study if they: - Are HIV-positive. - Are at highest risk for HIV infection. - Are pregnant or breast-feeding. - Are allergic to eggs or neomycin. - Use certain prescription medications.
Total Enrollment: 36
Location and Contact Information:
Overall Study Official:
MaryMarovich, Principal Investigator,
Walter Reed Army Institute of Research (WRAIR)
Rockville, Maryland, 20850
United States
Additional Information:
Study ID Numbers: B011; RV 138
Study Start Date:
Record last reviewed: March 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00013572
Other Hiv Seronegativity Studies:
1. A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
2. The Safety and Effectiveness of HBY 097 Used with or without AZT in HIV-Infected Patients Who Have Mild or No Symptoms
3. Roll-over Trial Only for HIV-1 Infected Subjects in Control Groups of Selected TMC114 Trials who Fail Treatment
4. A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients
5. ALVAC-HIV vCP1452 Alone and Combined with MN rgp120
Related Studies:
Other HIV Seronegativity Clinical Trials
Other Maryland Clinical Trials
Other Rockville Clinical Trials
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
|
|
|
|
|
|
|
|
